the other thing that he mentioned was that the best responses in the open trial were with the candidates that were less advanced. Which could translate well for the blinded trial results.
Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial, page-136
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
-0.001(12.5%) |
Mkt cap ! $18.62M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $18.65K | 5.305M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 50 | 57052005 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 125915200 | 27 |
View Market Depth
| Last trade - 14.28pm 29/08/2024 (20 minute delay) ? |
| ATH (ASX) Chart |